Company: RPTX
Filing Date: 2025-11-17
Form Type: DEFA14A
Source: 0001193125-25-284040
Chunk: 66

Company: Repare Therapeutics Inc.
Filing Date: 2025-11-17
Form: DEFA14A
Chunk 66
---
 with Section 8.2 and Section 8.3) terminate this Agreement and accept, approve, recommend or enter into any agreement, 
 understanding or arrangement in respect of such Superior Proposal prior to completion of the Arrangement and recommend or approve such Superior Proposal or make a Change of Recommendation, if and only if:                                 |

| (i) | such Superior Proposal did not arise, directly or indirectly, as a result of a violation by the Company of                           
 Section 6.1, and the Company has been and continues to be in compliance with its obligations under Section 6.1 and this Section 6.2; |

| (ii) | the person making the Superior Proposal was not restricted from making such Superior Proposal pursuant to an 
 existing confidentiality, standstill or similar restriction;                                                 |

| (iii) | the Board of Directors has determined in good faith, after consultation with its outside legal counsel and 
 financial advisors, that such Acquisition Proposal constitutes a Superior Proposal;                        |

| (iv) | the Company has (A) delivered written notice to the Purchaser of the determination of the Board of                                                                                                                                      
 Directors that the Acquisition Proposal is a Superior Proposal and of the intention of the Board of Directors to accept, approve, recommend or enter into an agreement in respect of such Superior Proposal (the “Superior Proposal     
 Notice”) and (B) has provided the Purchaser with a copy of the acquisition or similar agreement relating to such Acquisition Proposal, including all supporting materials, including any financing documents supplied to the Company in 
 connection therewith and a written notice from the Board regarding the value in financial terms that the Board has, in consultation with an independent financial advisor, determined should be ascribed to any                         
 non-cash consideration offered under the Superior Proposal;                                                                                                                                                                             |

| (v) | at least five (5) Business Days have elapsed since the later of the date on which the Purchaser received a                                                                                                                     
 copy of the Superior Proposal Notice and the date on which the Purchaser received all the material specified in Section 6.2(b)(iv)(B) (such five Business Day period, the “Right to Match Period”) and, for greater certainty, 
 the Right to Match Period shall expire at 11:59 p.m. (Montréal time) on the last Business Day of the Right to Match Period;                                                                                                    |

| (vi) | if the Purchaser and Parent have offered to amend the terms of the Arrangement and this Agreement during the                                                                                                                                        
 Right to Match Period pursuant to